SCHEMBL7892210

SCHEMBL7892210

O=C(NCc1ccccc1)Nn1nc(-c2ccccc2)c2ccccc2c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ ADORA3 P0DMS8 2/20 0.50
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ TSHR P16473 2/20 0.49
▸ ADORA2A P29274 1/20 0.47
▸ POLB P06746 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ ENPP1 P22413 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ LMNA P02545 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7894602 0.86 ALDH1A1 (0.51) ALDH1A1ALOX15MEN1KMT2ATSHR
SCHEMBL7885140 0.81 ALOX15 (0.54) ALDH1A1ALOX15ADORA3MEN1KMT2A
SCHEMBL7892188 0.80 ALDH1A1 (0.53) ALDH1A1ALOX15MEN1KMT2ATSHR
SCHEMBL7893043 0.77 KMT2A (0.73) ALDH1A1ALOX15MEN1KMT2ATSHR
SCHEMBL30796074 0.76 ALDH1A1 (0.53) ALDH1A1MEN1KMT2APOLBLMNA
SCHEMBL1789674 0.76 ALDH1A1 (0.53) ALDH1A1MEN1KMT2APOLBLMNA
SCHEMBL1790108 0.76 MAPT (0.56) ALDH1A1ALOX15MEN1KMT2ATSHR
SCHEMBL30794643 0.76 MAPT (0.56) ALDH1A1ALOX15MEN1KMT2ATSHR
SCHEMBL30795705 0.76 ALDH1A1 (0.59) ALDH1A1ALOX15MEN1KMT2ALMNA
SCHEMBL1788479 0.76 ALDH1A1 (0.59) ALDH1A1ALOX15MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180629-B1 INDUCING OR PROMOTING APOPTOSIS AND FOR ARRESTING UNCONTROLLED NEOPLASTIC CELL PROLIFERATION, INCLUDING PRECANCEROUS AND CANCEROUS LESIONS CELL PATHWAYS, INC. 2001-01-30 — — US disclosed
Send feedback